Total Credits: 3 including 3 Category I CEs
The Medications in the Treatment of Opioid Use Disorders (MOUD) workshop is a three-hour, non-medical workshop aimed at improving interdisciplinary care considerations for clients receiving or considering medications in the treatment of Opioid Use Disorder. Basic information on common medications used in the treatment of Opioid Use Disorders including buprenorphine, methadone, and naltrexone will be covered. Best-practice approaches for coordinating with prescribers, supporting the client's whole-person recovery efforts including OUD, and helping clients through advocacy and support for clients in coping with bias and discrimination will be reviewed.
Dr. Bernard Showers, DSW, LCSW, earned his MSW at Shippensburg University in 2010. He is currently employed as an Adjunct Professor with several universities, including the University of Kentucky, the University of Maryland, and Simmons University. Bernard has over ten years of experience as a licensed social worker. He provides therapy for various ages and presenting problems; however, he specializes in treating substance use disorders, co-occurring disorders, anxiety, and depression. He employs an eclectic approach to therapy by utilizing various evidence-based practices, including Motivational Interviewing, Cognitive Behavioral Therapy, and Acceptance and Commitment Therapy.
He is currently one of approximately 1,500 Motivational Interviewing Network of Trainers (MINT) members worldwide. Mr. Showers has trained aspiring and active independent practitioners at many colleges, universities, governmental agencies, and companies around the United States. In addition to Motivational Interviewing, Mr. Showers has developed, presented, and published several continuing education workshops on family involvement in substance use treatment, ASAM criteria, Cognitive Behavioral Therapy, and group therapy. The Beck Institute has also trained Mr. Showers in Cognitive Behavioral Therapy.
Bernard is a graduate of the inaugural class of The University of Kentucky's Doctorate of Social Work (DSW) Program. In July 2021, Bernard Showers was the lead author on the manuscript “Medication for Opioid Use Disorder in Rural America: A Review of the Literature,” published in the APA's Journal of Rural Mental Health. He is passionate about bringing awareness and solutions to enhance social work students' preparedness in meeting the nation's micro-, mezzo-, and macro-level substance use needs, as examined in his doctoral capstone project, Substance use education in social work programs: Time for a mandate?
AGENDA:
8:50 am – 9:00 am Log on
9:00 am – 9:45 am Introduction to MOUD
Medication Overview
History of MOUD
Challenges with Access to MOUD
The American Opioid Epidemic
9:45 am – 10:30 am Medications
Methadone
Buprenorphine
Naltrexone
10:30 am - 10:45 am BREAK
10:45 am – 12:00 pm Interdisciplinary Care
Historical Considerations
Stigma
Harm reduction approaches
Creating A Supportive Treatment Environment
Communication Between Providers
12:00 pm – 12:15 Resources
Current evidence on efficacy of MOUD
Review of Local, State, and National Resources
12:15 Adjournment
LEARNING OBJECTIVES:
Upon the completion of this workshop, participants will be able to:
Describe the major differences between medications commonly used in treatment of Opioid Use Disorders.
Create a supportive environment for clients receiving MOUD.
Discuss the efficacy of MOUD.
Identify local, state, and federal resources to support their clients receiving MOUD.
BIBLIOGRAPHY & REFERENCES
AJMC. (2021). AJMC. https://www.ajmc.com/view/an-overview-of-medication-assisted-treatment-for-opioid-and-alcohol-use-disorders
Anddrilla, H.C., Coulthard, C., & Patterson, D. G. (2018a). Prescribing practices of rural physicians waivered to prescribe Buprenorphine. American Journal of Preventive Medicine, 54(6), S208-S214. https://doi.org/10.1016/j.ampre.2018.02.006
Anddrilla, H.C., Moore, T.E., & Patterson, D.G., & Larson,E.H. (2018b) Geographic distribution of providers with a DEA waiver to prescribe Buprenorphine for the treatment of Opioid Use Disorder: A 5‐year update. The Journal of Rural Health, 35(6),108-112. https://doi-org.ezproxy.uky.edu/10.1111/jrh.12307
Centers for Disease Prevention and Control. (2019). Annual surveillance report of drug-related risks and outcomes. https://www.cdc.gov/drugoverdose/pdf/pubs/2019-cdc-drug-surveillance-report.pdf
Connock, M., Juarez-Garcia, A., Jowett, S., Frew, E., Liu, Z., Taylor, R. J., &Taylor, R. S. (2007). Methadone and buprenorphine for the management of opioid dependence: A systematic review and economic evaluation. Health Technology Assessment, 11(9), 1– 171. DOI: 10.3310/hta11090
Council of Economic Advisors. (2017). The underestimated cost of the opioid crisis. https://www.whitehouse.gov/sites/whitehouse.gov/files/images/The%20Underestimated%20Cost%20of%20the%20Opioid%20Cris.pdf.
CQ Researcher. (2020). Issues for debate in social policy. (3rd ed.) Sage Press.
Edmond, M.B., Aletraris, L., & Roman, P.M. (2015). Rural substance treatment centers in the United States: An assessment of treatment quality by location. American Journal of Drug and Alcohol Abuse, 41(5), 449-457. doi: 10.3109/00952990.2015.1059842
Hancock, C., Mennenga,H., King, N., Andrilla, H.C., Larson, E.H., Schou, P. (2017) Treating the rural opioid epidemic. National Rural Health Association. https://www.ruralhealthweb.org/NRHA/media/Emerge_NRHA/Advocacy/Policy%20documents/Treatingthe-Rural-Opioid-Epidemic_Feb-2017_NRHA-PolicyPaper.pdf.
Kelly, J.F., Dow, S.J., & Westerhoff, C. (2010). Does our choice of substance-related terms influence perceptions of treatment need? An empirical investigation with two commonly used terms. Journal of Drug Issues, 40(4), 805-818.
Moody, L. N., Satterwhite, E., & Bickel, W.K. (2017). Substance use in rural Central Appalachia: Current status and treatment considerations. Journal of Rural Mental Health, 41(2), 123-125. https://doiorg.proxyhs.researchreport.umd.edu/10.1037/rmh0000064
SAMHSA (2022). Harm reduction. SAMHSA. https://www.samhsa.gov/find-help/harm-reduction
SAMHSA. (2021) TIP 63: Medications for Opioid Use Disorder. SAMHSA. https://store.samhsa.gov/product/TIP-63-Medications-for-Opioid-Use-Disorder-Full-Document/PEP21-02-01-002
Siegel, J. (2019). Rural hospital closures rise to ninety-eight. Rural Health Voices. National Rural Health Association. https://www.ruralhealthweb.org/blogs/ruralhealthvoices/february-2019/rural-hospital-closures-rise-to-ninety-seven
United States Department of Health and Human Services. (2020, September 19). Opioid crisis statistics. HHS. https://www.hhs.gov/opioids/about-the-epidemic/opioid-crisis-statistics/index.html
Volkow ND, Frieden TR, Hyde PS, Cha SS. (2014) Medication-assisted therapies--Tackling the opioid overdose epidemic. New England Journal of Medicine.370(22), 2063-2066. doi:10.1056/NEJMp1402780.
Wakeman, S.E., & Rich, J.D. (2018) Barriers to medications for addiction treatment: How stigma kills, Substance Use & Misuse, 53(2), 330-333. DOI: 10.1080/10826084.2017.1363238
Wilkerson, R.G., Hong, K.K., Windsor, T.A., & Mareiniss, D.P. (2016). The opioid epidemic in the United States. Emergency Medical Clinics of North America. 34(2), https://www-clinicalkey-com.ezproxy.uky.edu/#!/content/playContent/1-s2.0-S073386271500108X?returnurl=null&referrer=null
Category I Maryland BSWE Requirement
The Office of Continuing Professional Education at the University Of Maryland School Of Social Work is authorized by the Board of Social Work Examiners in Maryland to sponsor social work continuing education programs. This workshop qualifies for {3} Category I Continuing Education Units Maryland Board of Professional Counselors to sponsor Category A continuing professional education.
Please refer to the tab "Live Interactive Webinar Policies & FAQs" for UMSSW Office of CPE policies regarding all live interactive webinar related matters.
Social Workers, LCPCs, and Psychologists
We welcome anyone interested in the topic!
LIVE INTERACTIVE WEBINAR PLATFORMS
The Office of Continuing Professional Education hosts Live Interactive Webinars through two platforms: Zoom and WebEx.
Both platforms offer high quality and user-friendly webinar platforms for our registrants.
System Requirements:
Our system is not compatible with the Safari web browser.
**Please have your device charging at all times to ensure that your device does not lose power during the webinar.
Course Interaction Requirements:
To participate in Live Interactive Webinars, you MUST have a device that allows you to view the presentation on screen and hear the instructor at all times. We do not allow participants to call-in from their phones or mobile devices and solely listen to the presentation. Participation in Live Interactive Webinars is mandatory.
Click The Link to View The Webinar Policies & FAQs
https://umbsswcpe.ce21.com/Page/live-interactive-webinar-procedures-policies-4129
If you are requesting ADA accommodations, please contact our office via email at least two weeks prior to the workshop date. Requests after that date may not be fulfilled.
Our email address is cpe@ssw.umaryland.edu.